Published August 28, 2026
This one came across our desk from a news source on 2026-09-02 — 'BMJ network meta-analysis of 262 trials ranks 19 obesity…'. Our job here is the translation layer: what the headline means in protein, fiber and fat terms, and what stays unchanged on your plate no matter what the news says.
This story is on our radar. We cover GLP-1 news by checking the source and connecting it to the food data we maintain — protein, fiber, fat, and the same verdict we would give that food in any other post. Where a story makes food claims, the USDA data is the referee.
The pattern behind almost every GLP-1 food question is the same three variables, and it is worth restating because headlines keep circling back to it: protein protects muscle during weight loss, fat predicts nausea on a slowed stomach, and fiber plus water manages constipation. The same three checks sit behind every verdict here.
A news story about GLP-1s — whatever the angle — rarely changes the food math. It can change which nutrients get attention, which is why this site's verdict labels exist: they are a stable reference that works regardless of the news cycle.
A clear boundary keeps this site useful: it answers what is in the food, and it stops there. Whether a headline applies to your dose or your treatment is a question for your clinician — this post says that explicitly rather than blurring the line.
Our coverage filter is simple and it applies to every story: recent, traceable to a named source, and relevant to the food side of GLP-1 life. Anything that cannot be linked does not get a page — the same rule the site applies to its food data.
What this story changes on your plate: traceable sources and food data.
Protein first, vegetables second, small servings of the heavy stuff — the same structure as every other day, whatever the news.
Fat is the nausea lever and fiber-plus-water is the regularity lever; those two rules cover most of what side-effect headlines describe.
And the standing rule: news informs, it does not prescribe — your dose and symptom questions are for your clinician.
The week view is repeatable: same shape, same checks, week after week. Repeatability is what turns good advice into results. The run, not the single plate, is what the method here is designed to support.
If the scoring system designed a plate, it would look like this: a protein that scores green at 20g+ per 100g, vegetables covering the fiber half, a small quarter for what you want, and the sauce on the side. The values behind each choice are on the linked pages, which is the whole point — nothing here needs to be taken on faith. The point is that the structure, not the specific foods, is what carries the pattern.
A verdict here can say what a food contains, how it scores against published thresholds, and which preparation usually sits best on a GLP-1. It cannot recommend a dose, decide whether a symptom needs treatment, or judge how your condition and your medication interact. That is the provider's territory, and this site says so explicitly rather than blurring the line. The food side is what the published values can verify; the rest is the clinician's.
Relevance is mostly indirect: a study changes which nutrient gets attention, not the food pattern itself. The pattern — protein first, portions small, fiber and water constant — survives every headline, and the published thresholds are the reference for whichever nutrient the story highlights. Your dose and treatment questions remain your clinician's job.
No headline changes the data on this site. Food verdicts come from USDA values and guideline frameworks, not from any single story — a study can update the framework, but a single news cycle does not move the per-100g numbers. Patterns, not panic, are the response, and the pattern is the same plate: protein first, vegetables second, heavy food in small servings, water throughout.
Look for three things: a named source, a recent date, and a study or agency standing behind the claim. Journals like JAMA and NEJM and agencies like the FDA clear the bar; link-less headlines do not. Be skeptical of any story that overstates a single trial. This post names and links its source — the same standard we use for everything on the site.
Weekly is a good rhythm. The plate guidance shifts slowly, so there is no advantage to reading every headline the day it lands; the stable verdicts here cover the food side regardless. If a story does affect your treatment, the right next step is a conversation with your provider, not another article.
Source: a news source · 2026-09-02. The source is linked; the food-relevant part is analyzed; anything beyond the headline is not paraphrased.
This is a reference page, written by the editorial team that maintains the site's database: USDA values, a consistent screen, named frameworks. It is informational only, and it does not substitute for your clinician's judgment on anything medical. The method and the sources are the same across the whole site.
Not every GLP-1 story deserves its own post, but this one from AAO/NANOS consensus statement in Ophth
990 adverse-event reports on compounded semaglutide: what…The headline first: '990 adverse-event reports on compounded semaglutide: what…', reported by a news
What happens to weight after stopping GLP-1s: a Cleveland…We follow the GLP-1 news the way we follow food data: note the source, check the claims, and write only what c